WHO/Abdalrhman Ismail
© Credits

Chemical safety

    Overview

    Chemicals are essential for economic development and well-being, but can pose significant risks to human health if not managed in a sound way.

    Hazardous chemicals such as asbestos, lead, mercury, other toxic metals, polychlorinated and polyfluorinated compounds (thousands of chemicals that are toxic, extremely resistant to degradation in the environment, and bioaccumulating in food chains), and many others can be present in a variety of items and settings. These include food, household and agriculture products, cosmetics, building materials, occupational settings, and the environment (indoor and ambient air, water, soil).

    These chemicals can cause acute and chronic health disorders throughout the life-course, leading to diseases such as cancers; urinary, reproductive, cardiovascular and respiratory diseases; allergies; neurodevelopmental and congenital disorders; and endocrine disruption.

    With an ever-increasing number and volume of chemicals and chemical products used in daily life, human exposure to chemical agents is also likely to increase. Governments and other stakeholders involved in chemicals management should hence make additional efforts to protect health from hazardous exposure.

    Impact

    In the WHO European Region, exposure to selected chemicals is estimated to have caused 269 500 deaths in 2019. This figure is most likely underestimated, since it is based on evaluations for the few chemicals or groups of chemicals for which relevant scientific data are available.

    WHO response

    In the WHO European Region and globally, WHO prioritizes the protection of the population, especially of children as the most vulnerable group, from exposure to hazardous chemicals.

    To this end, WHO promotes non-hazardous or less hazardous alternatives and other health protection interventions in countries, such as implementation of relevant agreements; strengthening of policies and the legal basis for the regulation of chemicals, their mixtures and wastes; capacity-building; and awareness-raising.

    WHO also promotes the use of tools and instruments to assess exposure and risk to justify decisions to prevent or minimize impacts, and advocates for greater involvement of the health sector to bring a public-health perspective into policy-making.

    WHO supports countries’ efforts to reduce and eliminate health risks from exposure to hazardous chemicals, including within the framework of global and regional commitments. Priority areas are:

    • developing methodologies and tools to assess exposure to chemicals and risk for health;
    • providing advice on the development of national policies, strategies and regulations for chemicals management, ensuring involvement of all stakeholders and greater involvement of the health sector;
    • promoting the establishment and strengthening of institutional infrastructure in the health sector needed for improving chemicals management, such as poison centres;
    • encouraging the use of safe materials as alternatives to hazardous chemicals such as lead, mercury, pesticides and endocrine-disrupting chemicals;
    • advocating for the reduction of releases of hazardous chemicals into the environment, in particular persistent and so-called forever chemicals, pharmaceuticals, pesticides, and endocrine-disrupting chemicals, and for the reduction of their use in consumer products; and
    • facilitating the collection, exchange and availability of information.

    Our work

    All →
    Reducing health risks from asbestos

    Reducing health risks from asbestos

    WHO/Peter Larsen
    © Credits

    Overview

    European ministers of health and environment committed themselves in the Parma and Ostrava Declarations to act with priority on the establishment by 2015 of national programmes to eliminate asbestos-related diseases. Many Member States in the WHO European Region have already established such programmes. WHO/Europe and the International Labour Organization are supporting countries’ efforts through the provision of information, training and policy and technical guidance.

    Exposure to asbestos can occur at the workplace or in the environment through inhalation of dust containing asbestos fibres. According to the International Agency for Research on Cancer (IARC), asbestos accounted for about 50% of occupational lung cancers; in particular, 85–90% of male mesothelioma cases are due to occupational exposure to asbestos. Because of the long latency period between exposure and disease development – especially in the case of mesothelioma – the number of asbestos-related diseases is still rising, even in countries that banned the use of asbestos more than 20 years ago.

    All forms of asbestos are banned from use in more than half of Member States in the WHO European Region because exposure of workers and other users is extremely difficult to control, and because asbestos abatement is very costly and hard to carry out in a completely safe way. While safer substitutes are being introduced for all uses, safe removal and disposal of existing asbestos remains a challenge.

    National and international policy development for the elimination of asbestos-related diseases is based on the following milestones:

    • quantification of the burden of asbestos-related diseases in Europe;
    • preparation of national asbestos profiles;
    • preparation of regional asbestos profiles;
    • preparation of national programmes and action plans;
    • preparation of the WHO report to the Sixth Ministerial Conference on Environment and Health (2017).

    Publications

    All →
    Planning the implementation of global and regional chemical safety policies: Bonn, Germany, 4–6 June 2024: meeting report

    New policies for the management of chemicals were adopted recently to ensure a higher level of protection of human health and the environment from the...

    Activities to facilitate national human biomonitoring programmes in the WHO European Region

    The Seventh Ministerial Conference on Environment and Health (‎5–7 July 2023, Budapest, Hungary)‎ established a new mechanism to facilitate...

    Documents

    All →

    Related WHO collaborating centres

    WHO collaborating centres are institutions that form an international collaborative network carrying out activities to support WHO’s programmes at all levels. They provide an opportunity for WHO to utilize their inherent expertise for the benefit of all Member States.

    View the list of related collaborating centres